Abstract
persistence of M5717 treated iRBCs in the bloodstream is likely due to reduced cytoadherence and splenic clearance.
Schneider MP, Looker O, Rebelo M, Khoury DS, Dixon MWA, Oeuvray C, Crabb BS, McCarthy J, Gilson PR
VIEW FULL ARTICLEJournal Frontiers in cellular and infection microbiology
Published 29 Jun 2023
Volume 13
Pagination 1211613
DOI 10.3389/fcimb.2023.1211613
persistence of M5717 treated iRBCs in the bloodstream is likely due to reduced cytoadherence and splenic clearance.